Use of AB-103 (a "dual antagonist") in the treatment of bronchogenic carcinoma.
D000970:Antineoplastic Agents / Q000628:therapy*; D002277:Carcinoma; D002283:Carcinoma, Bronchogenic / Q000628:therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents
ANTINEOPLASTIC AGENTS/therapy; CARCINOMA, BRONCHOGENIC/therapy; LUNG NEOPLASMS/therapy